Evaluation of children with a suspected bleeding disorder applying the Impact-R [Cone and Plate(let) Analyzer]

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 12, 2009, Pages 1990-1996

  Revel Vilk, S ^a   Varon, D ^a   Shai, E ^a   Agmon, Y ^a   Hyam, E ^a   Daas, N ^b   Miskin, H ^c   Weintraub, M ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BIKUR CHOLIM HOSPITAL   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Bleeding disorder; Impact R method; Platelet dysfunction; Screening; Von Willebrand disease

Indexed keywords

ADOLESCENT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; CHILD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; EVALUATION; FAMILY HEALTH; FEMALE; HUMAN; INFANT; INSTRUMENTATION; MALE; MASS SCREENING; METHODOLOGY; PRESCHOOL CHILD; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; THROMBOCYTE DISORDER;

ADOLESCENT; BLOOD COAGULATION DISORDERS; BLOOD PLATELET DISORDERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FAMILY HEALTH; FEMALE; HUMANS; INFANT; MALE; MASS SCREENING; PLATELET FUNCTION TESTS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 77449152531     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03628.x     Document Type: Article

References (31)

1. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 893-8.
2. Salles II, Feys HB, Iserbyt BF, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Inherited traits affecting platelet function. Blood Rev 2008; 22: 155-72.
3. Cariappa R, Wilhite TR, Parvin CA, Luchtman-Jones L. Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems. J Pediatr Hematol Oncol 2003; 25: 474-9.
4. Favaloro EJ, Facey D, Henniker A. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders. Am J Hematol 1999; 62: 165-74.
5. Karger R, Donner-Banzhoff N, Muller HH, Kertschmer V, Hunink M. Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history - a systematic review and meta-analysis. Platelets 2007; 18: 249-60.
6. Hayward CP, Harrison P, Cattaneo M, Ortel TL, Rao AK. Platelet function analyzer (PFA)-100closure time in the evaluation of platelet disorders and platelet function: reply to a rebuttal. J Thromb Haemost 2006; 4: 1433-4.
7. Kratzer MA. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function: a rebuttal. J Thromb Haemost 2006; 4: 1845-6.
8. Shenkman B, Savion N, Dardik R, Tamarin I, Varon D. Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor. Thromb Res 2000; 99: 353-61.
9. Kenet G, Lubetsky A, Shenkman B, Tamarin I, Dardik R, Rechavi G, Barzilai A, Martinowitz U, Savion N, Varon D. Cone and platelet analyzer (CPA): a new test for the prediction of bleeding among thrombocytopenic patients. Br J Haematol 1998; 101: 255-9.
10. Gerrah R, Snir E, Brill A, Varon D. Platelet function changes as monitored by cone and plate(let) analyzer during beating heart surgery. Heart Surg Forum 2004; 7: E191-5.
11. Spectre G, Brill A, Gural A, Shenkman B, Touretsky N, Mosseri E, Savion N, Varon D. A new point-of-care method for monitoring anti-platelet therapy: application of the cone and plate(let) analyzer. Platelets 2005; 16: 293-9.
12. Albanyan AM, Murphy MF, Harrison P. Evaluation of the Impact-R for monitoring the platelet storage lesion. Platelets 2009; 20: 1-6.
13. Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, Turecek PL, Lillicrap D, Rand ML. von Willebrand disease in a pediatric-based population - comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost 2000; 84: 401-9.
14. Hedlund-Treutiger I, Revel-Vilk S, Blanchette VS, Curtin JA, Lillicrap D, Rand ML. Reliability and reproducibility of classification of children as "bleeders" versus "non-bleeders" using a questionnaire for significant mucocutaneous bleeding. J Pediatr Hematol Oncol 2004; 26: 488-91.
15. National Heart, Lung, and Blood Institute. The Diagnosis, Evaluation, and Management of von Willebrand Disease. NIH Pub. No. 08-5832. December, 2007.
16. Nurden AT. Glanzmann thrombasthenia. Orphanet J Rare Dis. 2006; 1: 10.
17. Levy-Shraga Y, Maayan-Metzger A, Lubetsky A, Shenkman B, Kuint J, Martinowitz U, Kenet G. Platelet function of newborns as tested by cone and plate(let) analyzer correlates with gestational age. Acta Haematol 2006; 115: 152-6.
18. Carcao MD, Blanchette VS, Dean JA, He L, Kern MA, Stain AM, Sparling CR, Stephens D, Ryan G, Freedman J, Rand ML. The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol 1998; 101: 70-3.
19. Abramson JH. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspec Innov 2004; 1: 6.
20. Varon D, Dardik R, Shenkman B, Kotev-Emeth S, Farzame N, Tamarin I, Savion N. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997; 85: 283-94.
21. Podda GM, Bucciarelli P, Lussana F, Lecchi A, Cattaneo M. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time. J Thromb Haemost 2007; 5: 2393-8.
22. Revel-Vilk S, Schmugge M, Mannuel C, Blanchette P, Rand ML, Blanchette V. Desmopressin (DDAVP) responsiveness in children with von Willebrand Disease. J Pediatr Hematol Oncol 2003; 25: 874-9.
23. Coppola A, Di Minno G. Desmopressin in inherited disorders of platelet function. Haemophilia 2008; 14 (Suppl. 1): 31-9.
24. Rodeghiero F, Kadir RA, Tosetto A, James PD. Relevance of quantitative assessment of bleeding in haemorrhagic disorders. Haemophilia 2008; 14(Suppl. 3): 68-75.
25. Rodeghiero F, Castaman G, Tosetto A, Battle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JC, Federici AB, Lethagen S, Linari S, Srivastava A. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005; 3: 2619-26.
26. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766-73.
27. Biss TT, Blanchette VS, Bowmann M, Clark DS, Silva M, Lillicrap D, James PD, Rand ML. Quantitation of bleeding symptoms in children with von Willebrand disease (VWD) or a platelet function disorder: use of a standardized pediatric bleeding score. Blood (ASH Annual Meeting Abstracts) 2007; 110: 2137.
28. Hyatt SA, Wang W, Kerlin BA, O'Brien SH. Applying diagnostic criteria for type 1 von Willebrand disease to a pediatric population. Pediatr Blood Cancer 2009; 52: 102-7.
29. Quiroga T, Goycoolea M, Panes O, Aranda E, Martinez C, Belmont S, Munoz B, Zuniga P, Pereira J, Mezzano D. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 2007; 92: 357-65.
30. Shaw PH, Reynolds S, Gunawardena S, Krishnamurti L, Ritchey AK. The prevalence of bleeding disorders among healthy pediatric patients with abnormal preprocedural coagulation studies. J Pediatr Hematol Oncol 2008; 30: 135-41.
31. Flahault A, Cadilhac M, Thomas G. Sample size calculation should be performed for design accuracy in diagnostic studies. J Clin Epidemiol 2005; 58: 859-62.